A person looks through a door into a closed community vaccination center administering the BioNTech Covid-19 vaccine in Hong Kong on March 24th.
Photographer: Kyle Lam / Bloomberg
Photographer: Kyle Lam / Bloomberg
Hong Kong expects initial conclusions of a study into BioNTech SE Covid-19 vaccine packaging deficiencies as early as next week, the South China Morning Post was reported Saturday, announcing a chief executive.
Patrick Nip, secretary of the civil service, personally named the senior regional distributors of Shanghai Fosun Pharmaceutical Group Co. to ask newcomers of the vaccine if safety concerns arise with the existing batches in Hong Kong, the newspaper said it said.
A closing sign outside a community vaccination center administering the BioNTech Covid-19 vaccine in Hong Kong on March 24th.
Photographer: Kyle Lam / Bloomberg
Hong Kong will give priority to those who need to raise blows when the BioNTech vaccine begins, it was reportedly told on a radio show. He hoped that people would be able to get a second dose by mid-April.
Read more about Hong Kong BioNTech vaccine prevention
The government started giving vaccines on March 6, with recipients ready to take the elevated picture after 21 days. Hong Kong and Macau stopped using the vaccine on Wednesday, as BioNTech and Fosun began probing into tilted or loose vial caps and minor stains on a small number of bottles.